Markets:

Overview

News

Currencies

International

Treasuries

Viridian Therapeutics, Inc. - Common Stock (NQ:VRDN)

14.78 -0.17 (-1.14%)

Streaming Delayed Price Updated: 11:52 AM EDT, Apr 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viridian Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Viridian Therapeutics Appoints New Chief Executive Officer, Unveils Next Generation FcRn Inhibitor Programs and Announces $185 Million Private Placement Financing

October 30, 2023

From Viridian Therapeutics, Inc.

Via Business Wire

Viridian Therapeutics Enters Autoinjector Pen Device Customization and Supply Agreement with Ypsomed AG for Subcutaneous Drug Delivery in Thyroid Eye Disease

October 26, 2023

From Viridian Therapeutics, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

October 03, 2023

On Tuesday, 647 companies set new 52-week lows.

Via Benzinga

Analyst Ratings for Viridian Therapeutics ↗

September 13, 2023

Via Benzinga

9 Analysts Have This to Say About Viridian Therapeutics ↗

August 09, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

September 28, 2023

During Thursday's session, 406 companies made new 52-week lows.

Via Benzinga

Viridian Appoints Sarah Gheuens, M.D., Ph.D., to its Board of Directors

September 25, 2023

From Viridian Therapeutics, Inc.

Via Business Wire

Viridian Therapeutics Announces Presentations at Multiple Medical Meetings in September

September 07, 2023

From Viridian Therapeutics, Inc.

Via Business Wire

Why Are Viridian Therapeutics Shares Falling Today ↗

July 11, 2023

Viridian Therapeutics Inc (NASDAQ: VRDN) released preliminary data from its ongoing Phase 1/2 trial of VRDN-001 for

Via Benzinga

11 Analysts Have This to Say About Viridian Therapeutics ↗

June 14, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

September 26, 2023

On Tuesday, 386 stocks made new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

September 21, 2023

During the session on Thursday, 461 stocks hit new 52-week lows.

Via Benzinga

Global Payments To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Thursday ↗

August 10, 2023

Keybanc cut the price target for i3 Verticals, Inc. (NASDAQ: IIIV) from $28 to $26. Keybanc analyst Josh Beck maintained an Overweight rating. i3 Verticals shares fell 2.9% to close at $22.76 on...

Via Benzinga

Viridian Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

August 08, 2023

From Viridian Therapeutics, Inc.

Via Business Wire

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

August 04, 2023

From Viridian Therapeutics, Inc.

Via Business Wire

2 Growth Stocks Wall Street Analysts Think Can Double in Value ↗

July 19, 2023

Is now a good time to buy these promising healthcare stocks?

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 11, 2023

Via Benzinga

Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 11, 2023

Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares climbed 129.5% to $8.01 after gaining 9% on Monday.

Via Benzinga

Why Shares of Viridian Therapeutics Are Falling Tuesday ↗

July 11, 2023

The company announced preliminary trial results for its lead therapy.

Via The Motley Fool

Viridian Wants To Take On Horizon; Why This Update In Thyroid Eye Disease Fell Flat ↗

July 11, 2023

Shares tumbled after the biotech company unveiled the results of its chronic TED treatment.

Via Investor's Business Daily

Why These 2 Nasdaq Biotech Stocks Fell Hard Tuesday Morning ↗

July 11, 2023

Broader markets seemed likely to start out on a positive note despite these two outliers.

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 11, 2023

Via Benzinga

Why Better Therapeutics Are Trading Higher By 51%; Here Are 20 Stocks Moving Premarket ↗

July 11, 2023

Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares surged 109.2% to $7.30 in pre-market trading after gaining 9% on Monday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

July 11, 2023

It's time for another breakdown of the biggest pre-market stock movers as we check out all of the shares rising and falling on Tuesday!

Via InvestorPlace

JetBlue Airways, VOXX International And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

July 11, 2023

U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Viridian Announces Positive Data from Ongoing Phase 1/2 Trial Evaluating VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED)

July 10, 2023

From Viridian Therapeutics, Inc.

Via Business Wire

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

July 06, 2023

From Viridian Therapeutics, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023 ↗

June 14, 2023

Via Benzinga

Viridian Therapeutics Announces Presentations at the 2023 Annual Meeting of the Endocrine Society

June 13, 2023

From Viridian Therapeutics, Inc.

Via Business Wire

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 05, 2023

From Viridian Therapeutics, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.